SM

Sandrine Mace

SA Sanofi-Aventis: 8 patents #170 of 1,008Top 20%
AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
SA Sanofi-Aventis: 1 patents #285 of 563Top 55%
SS Serono Genetics Institute S.A.: 1 patents #30 of 62Top 50%
📍 Jouy-en-Josas, FR: #3 of 39 inventorsTop 8%
Overall (All Time): #465,713 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
8420321 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism Detlef Kozian, Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze +1 more 2013-04-16
8198022 Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard +1 more 2012-06-12
8084198 Use of a GIP promoter polymorphism Detlef Kozian, Matthias Herrmann, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard 2011-12-27
7985562 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism Detlef Kozian, Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze +1 more 2011-07-26
7892744 Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders Detlef Kozian, Joerg Czech, Karl-Ernst Siegler, Jean-Francois Deleuze, Sylvain Ricard 2011-02-22
7888020 Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Sylvain Ricard +1 more 2011-02-15
7803538 Method for detecting Alzheimer's disease Sylvain Ricard, Emmanuelle Cousin, Laurent Pradier, Jesus Benavides, Jean-Francois Deleuze 2010-09-28
7785781 Method of diagnosis of a predisposition to develop thrombotic disease and its uses Detlef Kozian, Matthias Herrmann, Jean-Francois Deleuze, Sylvain Ricard 2010-08-31
7560290 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism Detlef Kozian, Stefan Schaefer, Bernward Schoelkens, Karl-Ernst Siegler, Jean-Francois Deleuze +1 more 2009-07-14
7358066 Variants and exons of the GlyT1 transporter Gilbert Thill, Philippe Jais, Pascale Grel 2008-04-15
7262273 Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof Detlef Kozian, Evi Kostenis, Karl-Ernst Siegler, Martina Jacobs, Jean-Francois Deleuze +1 more 2007-08-28